As of October 1, 2025, Prof. Dr. med. Dr. h.c. Matthias H. Tschöp is serving as President of Ludwig-Maximilians-Universität München (LMU). The internationally renowned physician and medical researcher previously led Helmholtz Munich and was Vice President of the Helmholtz Association for Health Research. With his groundbreaking discoveries – including the identification of the hunger hormone ghrelin and the development of polyagonists, the most effective medicines to date against obesity and type 2 diabetes – Tschöp has profoundly shaped modern metabolic research. His pioneering work has earned him numerous prestigious international awards and recognition as one of the most influential medical scientists of his generation. As President, he pursues a bold vision for the future: to further strengthen LMU’s role as a globally visible university of excellence – a hub for world-class research, a home for inspiring teaching, and an independent forum for responsible societal discourse. Tschöp sees LMU’s unique breadth as a comprehensive university as a decisive strength. Such diversity enables bridges across disciplines – from natural and life sciences to the humanities and social sciences – opening new perspectives and creative solutions to the complex challenges of our time. Emerging technologies such as artificial intelligence will not only be actively employed at LMU, but also critically advanced and rigorously reflected upon. Equally important to Tschöp is a modern, team-oriented style of university leadership. Together with an expanded presidium, he seeks to shape LMU through open communication, transparency, and interdisciplinary collaboration. His goal: a university that exemplifies the integration of scientific excellence, societal responsibility, and global openness.